Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Cash (2016 - 2025)

Collegium Pharmaceutical has reported Change in Cash over the past 10 years, most recently at $81.2 million for Q4 2025.

  • Quarterly results put Change in Cash at $81.2 million for Q4 2025, up 156.79% from a year ago — trailing twelve months through Dec 2025 was $155.5 million (up 208.48% YoY), and the annual figure for FY2025 was $155.5 million, up 208.48%.
  • Change in Cash for Q4 2025 was $81.2 million at Collegium Pharmaceutical, up from $32.8 million in the prior quarter.
  • Over the last five years, Change in Cash for COLL hit a ceiling of $95.8 million in Q1 2023 and a floor of -$108.9 million in Q3 2024.
  • Median Change in Cash over the past 5 years was $12.1 million (2022), compared with a mean of $3.8 million.
  • Peak annual rise in Change in Cash hit 680.51% in 2022, while the deepest fall reached 1019.16% in 2022.
  • Collegium Pharmaceutical's Change in Cash stood at -$6.8 million in 2021, then soared by 680.51% to $39.6 million in 2022, then crashed by 149.5% to -$19.6 million in 2023, then soared by 261.37% to $31.6 million in 2024, then skyrocketed by 156.79% to $81.2 million in 2025.
  • The last three reported values for Change in Cash were $81.2 million (Q4 2025), $32.8 million (Q3 2025), and $21.2 million (Q2 2025) per Business Quant data.